SKI Market

Indian Indices

Nifty

26,053.90 117.70
(0.45%)

Sensex

84,752.66 -244.47
( -0.29%)

Bank Nifty

58,385.25 171.15
( 0.29%)

Nifty IT

36,090.10 229.70
( 0.64%)

Global Indices

Nasdaq

47,640.49 -86.88
(-0.18%)

Dow Jones

6,909.03 -2.86
(-0.04%)

Hang Seng

51,290.81 1,071.63
(2.13%)

Nikkei 225

9,748.97 52.23
(0.54%)

Forex

USD-INR

88.25 0.13
(0.15%)

EUR-INR

102.86 0.33
(0.32%)

GBP-INR

117.45 -0.02
(-0.02%)

JPY-INR

0.58 0.00
(0.68%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Novartis India Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500672

INE234A01025

313.912669

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

NOVARTIND

20.22

2155.75

EPS(TTM)

Face Value()

Div & Yield %

43.17

2.86

Back

Novartis India standalone net profit rises 7.30% in the June 2025 quarter

Jul 29,2025

Net profit of Novartis India rose 7.30% to Rs 27.62 crore in the quarter ended June 2025 as against Rs 25.74 crore during the previous quarter ended June 2024. Sales declined 5.14% to Rs 87.55 crore in the quarter ended June 2025 as against Rs 92.29 crore during the previous quarter ended June 2024.

Particulars	Quarter Ended
	Jun. 2025	Jun. 2024	% Var.
Sales	87.55	92.29	-5
OPM %	31.11	25.97	-
PBDT	37.75	34.23	10
PBT	37.22	33.68	11
NP	27.62	25.74	7

26,053.90 117.70 (0.45%)

84,752.66 -244.47 ( -0.29%)

58,385.25 171.15 ( 0.29%)

36,090.10 229.70 ( 0.64%)

47,640.49 -86.88 (-0.18%)

6,909.03 -2.86 (-0.04%)

51,290.81 1,071.63 (2.13%)

9,748.97 52.23 (0.54%)

88.25 0.13 (0.15%)

102.86 0.33 (0.32%)

117.45 -0.02 (-0.02%)

0.58 0.00 (0.68%)